Cardiac-related Hospitalization and/or Death Associated With Immune Dysregulation and Symptoms of Depression in Heart Failure Patients

Objective: Congestive heart failure (CHF) patients with depressive symptoms have a greater risk of morbidity and mortality. Immune activity such as inflammation is increasingly implicated as underlying this relationship. However, it is unknown whether there is a broader spectrum of immune dysregulation beyond inflammatory activity. This study examined in CHF patients the relationship of depressive symptoms with cellular immune activity measured by Th1/Th2 ratios and cardiac rehospitalization and/or death. Method: Eighteen patients with CHF (mean age = 62, NYHA classes II–IV) were enrolled and depressive symptoms were measured with interviewer ratings using the Hamilton Rating Scale-Depression. For the determination of Th1/Th2 ratios, intracellular cytokine expression of interferon-gamma (IFN-gamma) and interleukin-10 (IL-10) CD4+ T cells were measured by flow cytometry. Plasma interleukin-6 levels were measured to ascertain circulating inflammatory cytokine activity. Patient records were examined for cardiac related rehospitalization or cardiac related death over a two-year period after baseline depression and immune measures were taken. Results: Higher depression scores were associated with a prospective increase in incidence of cardiac related hospitalizations and/or death (p = .037). Lesser IFN-gamma/IL-10 expressing CD4+ T cell ratios were related to higher depressive symptom scores at baseline (p = .005) and a prospective increased incidence of cardiac related hospitalization or death over a two-year period (p = .05). Conclusions: A shift in the Th1/Th2 ratio may play a role in the association between depressive symptoms and morbidity and mortality in CHF patients, suggesting broader immune dysregulation than previously considered. CHF = congestive heart failure; IFN = interferon; IL = interleukin; NYHA = New York Heart Association; BNP = B-type natriuretic peptide; HAM-D = Hamilton Depression Scale; EF = ejection fraction; BMI = body mass index.

[1]  Alan S Maisel,et al.  How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. , 2006, American heart journal.

[2]  Lin Ying Liu,et al.  Human airway and peripheral blood eosinophils enhance Th1 and Th2 cytokine secretion , 2006, Allergy.

[3]  Y. Kihara,et al.  B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. , 2006, Journal of the American College of Cardiology.

[4]  I. Janszky,et al.  Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease , 2005, Brain, Behavior, and Immunity.

[5]  R. Carney,et al.  Depressive symptoms and the regulation of proinflammatory cytokine expression in patients with coronary heart disease. , 2005, Journal of psychosomatic research.

[6]  W. Chaplin,et al.  Role of depression and inflammation in incident coronary heart disease events. , 2005, The American journal of cardiology.

[7]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[8]  J. Cleland,et al.  Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction , 2005, European journal of heart failure.

[9]  D. Couper,et al.  Periodontal Disease and Coronary Heart Disease: A Reappraisal of the Exposure , 2005, Circulation.

[10]  P. Binkley,et al.  Depressive symptoms and inflammation among heart failure patients. , 2005, American heart journal.

[11]  Douglas L Mann,et al.  Mechanisms and models in heart failure: the biomechanical model and beyond. , 2005, Circulation.

[12]  X. Jouven,et al.  Contributions of Depressive Mood and Circulating Inflammatory Markers to Coronary Heart Disease in Healthy European Men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) , 2005, Circulation.

[13]  Bente Klarlund Pedersen,et al.  The anti-inflammatory effect of exercise. , 2005, Journal of applied physiology.

[14]  S. Zipfel,et al.  Depression increasingly predicts mortality in the course of congestive heart failure , 2005, European journal of heart failure.

[15]  A. Dogan,et al.  Are the high levels of cytomegalovirus antibodies a determinant in the development of coronary artery disease? , 2005, International heart journal.

[16]  D. Kass,et al.  Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Furze,et al.  Depressive symptoms and mortality in patients with congestive heart failure: a six-year follow-up study. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[18]  N. Rose,et al.  Interferon- Protects against Chronic Viral Myocarditis by Reducing Mast Cell Degranulation, Fibrosis, and the Profibrotic Cytokines Transforming Growth Factor- 1, Interleukin-1 , and Interleukin-4 in the Heart , 2004 .

[19]  R. Califf,et al.  Prognostic Value of Anxiety and Depression in Patients With Chronic Heart Failure , 2004, Circulation.

[20]  R. Krishnan,et al.  Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women , 2004, Psychoneuroendocrinology.

[21]  Edna Maria Vissoci Reiche,et al.  Stress, depression, the immune system, and cancer. , 2004, The Lancet. Oncology.

[22]  M. V. von Herrath,et al.  Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defense and immune pathology. , 2004, DNA and cell biology.

[23]  I. Elenkov.  Glucocorticoids and the Th1/Th2 Balance , 2004, Annals of the New York Academy of Sciences.

[24]  J. Lederer,et al.  Use of Intracellular Cytokine Staining and Bacterial Superantigen to Document Suppression of the Adaptive Immune System in Injured Patients , 2003, Annals of surgery.

[25]  A. Steensberg,et al.  IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. , 2003, American journal of physiology. Endocrinology and metabolism.

[26]  A. Steptoe,et al.  Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women , 2003, Psychological Medicine.

[27]  S. Anker,et al.  How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. , 2002, International journal of cardiology.

[28]  O. Tokunaga,et al.  Chlamydia pneumoniae and multiple infections in the aorta contribute to atherosclerosis , 2002, Pathology international.

[29]  Alan S Maisel,et al.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. , 2002, The New England journal of medicine.

[30]  A. Struthers.  Introducing a new role for BNP: as a general indicator of cardiac structural disease rather than a specific indicator of systolic dysfunction only , 2002, Heart.

[31]  E. Antman,et al.  ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .

[32]  D. Bush,et al.  Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. , 2001, The American journal of cardiology.

[33]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[34]  H. Krumholz,et al.  Depressive symptoms and risk of functional decline and death in patients with heart failure. , 2001, Journal of the American College of Cardiology.

[35]  M. D. de Baets,et al.  Inflammation, depressive symptomtology, and coronary artery disease. , 2000, Psychosomatic medicine.

[36]  G Baumgarten,et al.  Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Habbema,et al.  Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. , 2000, Statistics in medicine.

[38]  N. Frasure-smith,et al.  Depression in patients with cardiac disease: a practical review. , 2000, Journal of psychosomatic research.

[39]  M. Irwin,et al.  Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications. , 1999, The Journal of clinical endocrinology and metabolism.

[40]  E. Caine,et al.  The Importance of Subsyndromal Depression in Older Primary Care Patients: Prevalence and Associated Functional Disability , 1999, Journal of the American Geriatrics Society.

[41]  H. Feigenbaum.  Three-dimensional ultrasonic imaging of blood flow. , 1999, European heart journal.

[42]  S. Coppack,et al.  Adipose tissue as an endocrine and paracrine organ , 1998, International Journal of Obesity.

[43]  C. Chan,et al.  Cellular immunity to varicella-zoster virus in patients with major depression. , 1998, The Journal of infectious diseases.

[44]  Bruce Mcewen,et al.  Stress, Adaptation, and Disease: Allostasis and Allostatic Load , 1998, Annals of the New York Academy of Sciences.

[45]  D. Mann,et al.  Tumor Necrosis Factor- (cid:97) Confers Resistance to Hypoxic Injury in the Adult Mammalian Cardiac Myocyte , 2022 .

[46]  J S Yudkin,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo* , 2022 .

[47]  M. Rich,et al.  CONGESTIVE HEART FAILURE IN OLDER ADULTS * : Epidemiology, Pathophysiology, and Etiology of Congestive Heart Failure in Older Adults , 1997, Journal of the American Geriatrics Society.

[48]  P A Poole-Wilson,et al.  Six minute walking test for assessing exercise capacity in chronic heart failure. , 1986, British medical journal.

[49]  B. Brundage,et al.  Left Ventricular Volume from Paired Biplane Two‐dimensional Echocardiography , 1979, Circulation.

[50]  M. Hamilton,et al.  Development of a rating scale for primary depressive illness. , 1967, The British journal of social and clinical psychology.

[51]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[52]  R. Braun,et al.  Immunopathogenesis of Dilated Cardiomyopathy. Evidence for the Role of TH2-Type CD4+T Lymphocytes and Association with Myocardial HLA-DR Expression , 2006, Journal of Clinical Immunology.

[53]  J. Twisk,et al.  Stability and change of emotional functioning in late life: modelling of vulnerability profiles. , 2005, Journal of affective disorders.

[54]  N. Rose,et al.  Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. , 2004, The American journal of pathology.

[55]  M. Bourassa,et al.  Gender, depression, and one-year prognosis after myocardial infarction. , 1999, Psychosomatic medicine.

[56]  M. Irwin,et al.  Immune correlates of depression. , 1999, Advances in experimental medicine and biology.

[57]  H. Koenig,et al.  Depression in hospitalized older patients with congestive heart failure. , 1998, General hospital psychiatry.

[58]  C. Essau,et al.  How reliable are operationalized diagnosis? The test-retest reliability of Structured Clinical Interview for DSM-III-R (SCID) , 1992 .